
Will Crash or Slowdown Follow Boston’s Lab Boom?
It’s looking like the answer to the question of what to do with a piece of real estate is no longer just “convert it to life science space,” at least for a few years.
It’s looking like the answer to the question of what to do with a piece of real estate is no longer just “convert it to life science space,” at least for a few years.
Life science developer Alexandria Real Estate Equities is giving its first hints about its plans for its newest acquisitions in Watertown and Newton as it explores lab space growth in Boston’s inner suburbs.
Assembly Row and Cambridge Crossing are demonstrating how once-drab industrial parcels near the elevated decks of Interstate 93 can be reinvented as successful mixed-use developments. And developers are following a similar game plan at Charlestown’s Hood Park.
With a combination of low vacancy, high demand and some of the highest asking rents in the country, life science properties in the Boston metro are more desirable than ever for investment firms, both large and small.